ICD-10 Coding for Adrenal Gland Nodule(C74.9M, D35.0, D44.10N)
Comprehensive guide on ICD-10 coding for adrenal gland nodules, including documentation requirements, coding pitfalls, and billing considerations.
Complete code families applicable to Adrenal Gland Nodule
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| E27.9 | Unspecified disorder of adrenal gland | Use when imaging shows a non-functional nodule with benign characteristics. |
|
| D35.0x | Benign neoplasm of adrenal gland | Use when biopsy confirms benign nature of the adrenal lesion. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAdrenal Gland Nodule
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Adrenal Gland Nodule.
Failing to specify laterality of adrenal nodule
Impact
Clinical: Ambiguity in treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials.
Mitigation
Always document the side of the body affected., Use templates that prompt for laterality.
Using D35.0x without biopsy confirmation
Impact
Reimbursement: Incorrect billing for benign neoplasm without confirmation., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Ensure biopsy results are documented before using D35.0x.
Incorrect use of benign neoplasm codes
Impact
Using D35.0x without biopsy confirmation.
Mitigation
Require biopsy confirmation before coding as benign.